top of page
Home
About
Learn More
Team
News
ARVO
Contact
More
Use tab to navigate through the menu items.
All Posts
Regulatory
Licensing
Financial
Presentations
Pipeline
Search
FDA Pre-IND Consultation Completed
Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease LITTLE ROCK,...
Keith Ward
Mar 17, 2023
bottom of page